Related Experiment Videos
[Acute fulminant hepatic failure after short-term amiodarone]
1Dept. of Medicine B, Chaim Sheba Medical Center, Tel Hashomer.
Harefuah
|November 15, 1991
Summary
Amiodarone, a heart medication, can cause acute liver failure. This case highlights the potential for severe hepatic toxicity, even with short-term use, emphasizing the need for monitoring.
Area of Science:
- Hepatology
- Cardiology
- Clinical Pharmacology
Background:
- Amiodarone is a widely used antiarrhythmic drug.
- Congestive heart failure is a common comorbidity.
- Drug-induced liver injury is a significant clinical concern.
Observation:
- A 59-year-old male with congestive heart failure developed acute liver failure.
- The patient experienced liver failure within 4 days of initiating oral amiodarone loading dose.
Findings:
- Amiodarone-induced hepatotoxicity can manifest as pseudo-alcoholic hepatitis or phospholipidosis.
- Immune-mediated mechanisms may contribute to amiodarone hepatotoxicity.
Implications:
- Clinicians should consider amiodarone as a potential cause of acute liver failure, especially in patients with cardiac conditions.
- Early recognition and monitoring for hepatic adverse effects are crucial during amiodarone therapy.
- Further research into the immune mechanisms of amiodarone hepatotoxicity is warranted.